Reacto & Immunogenicity of TF Formulation of Influsplit SSW® 2002/03 v/s Std Formulation of Influsplit SSW® 2002/03

PHASE3CompletedINTERVENTIONAL

Enrollment

239

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

April 30, 2003

Conditions

Influenza

Interventions

BIOLOGICAL

Thiomersal free trivalent influenza split vaccine 2002/2003

Single dose, intramuscular injection

BIOLOGICAL

GlaxoSmithKline Biologicals' Influsplit SSW®/Fluarix™ 2002/2003

Single dose, intramuscular injection

Trial Locations (1)

GSK Clinical Trials Call Center, Dresden